Huaren Pharmaceutical Co., Ltd.
Huaren Pharmaceutical Co., Ltd., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has established a strong presence in both domestic and international markets, focusing on innovative solutions in areas such as oncology, cardiology, and infectious diseases. With a commitment to excellence, Huaren Pharmaceutical offers a diverse portfolio of core products, including generic medications and proprietary formulations that stand out for their efficacy and safety. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. Recognised for its dedication to quality and innovation, Huaren Pharmaceutical continues to contribute to global health advancements while maintaining a strong reputation in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Huaren Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huaren Pharmaceutical Co., Ltd.'s score of 26 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huaren Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Huaren Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 14,288,850 kg CO2e, with all emissions classified under Scope 1. The company's combined Scope 1 and 2 emissions reached about 152,103,450 kg CO2e. This marks an increase from 2022, when emissions were approximately 11,305,600 kg CO2e for Scope 1 and a total of about 108,596,090 kg CO2e for Scope 1 and 2 combined. Despite these figures, Huaren Pharmaceutical has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company does not currently report on Scope 2 or Scope 3 emissions, which limits the comprehensiveness of their climate impact assessment. Furthermore, there are no climate pledges or commitments to industry-standard initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) noted in their disclosures. Overall, while Huaren Pharmaceutical Co., Ltd. has provided emissions data for the past two years, the absence of reduction targets or climate commitments suggests a need for enhanced transparency and action in addressing their carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 11,305,600 | 00,000,000 |
| Scope 2 | - | - |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huaren Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
